Vertex Pharmaceuticals Inc. buy JPMorgan Chase & Co.
Start price
05.11.24
/
50%
€457.60
Target price
05.11.25
€460.55
Performance (%)
-19.86%
Price
15:17
€366.70
Summary
This prediction is currently active. The price of Vertex Pharmaceuticals Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -19.86%. This prediction currently runs until 05.11.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Vertex Pharmaceuticals Inc. | 3.461% | 3.461% |
iShares Core DAX® | 0.299% | 2.868% |
iShares Nasdaq 100 | 2.257% | 3.363% |
iShares Nikkei 225® | 5.054% | 8.119% |
iShares S&P 500 | 1.414% | 2.409% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target lowered by analysts at JPMorgan Chase & Co. from $510.00 to $503.00. They now have an "overweight" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€361.35
08.10.25
08.10.25
€455.85
08.10.26
08.10.26
2.13%
15:17
15:17
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€404.90
14.07.25
14.07.25
€442.35
14.07.26
14.07.26
-9.43%
15:17
15:17
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€387.85
06.05.25
06.05.25
€455.98
06.05.26
06.05.26
-4.85%
15:17
15:17
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€379.25
23.12.24
23.12.24
€480.45
23.12.25
23.12.25
-2.69%
15:17
15:17
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€432.30
05.08.24
05.08.24
€464.36
05.08.25
05.08.25
-24.98%
06.08.25
06.08.25
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€400.30
01.02.24
01.02.24
€404.41
01.02.25
01.02.25
10.22%
02.02.25
02.02.25